| P50 | author | Andrew Simmons | Q21094880 |
| | Simon Lovestone | Q30582986 |
| | Latha Velayudhan | Q51895272 |
| | Cristina Legido-Quigley | Q52448581 |
| | Michelle K Lupton | Q57010958 |
| | Magda N. Tsolaki | Q57073392 |
| | Bruno Vellas | Q66877204 |
| | Madhav Thambisetty | Q71775824 |
| | Alejo J Nevado-Holgado | Q90947136 |
| | Iwona Kłoszewska | Q38633661 |
| | Hilkka Soininen | Q38636823 |
| | Patrizia Mecocci | Q46713839 |
| | Petroula Proitsi | Q47504060 |
| P2093 | author name string | John F Powell | |
| | Richard J B Dobson | |
| | Min Kim | |
| | Stuart G Snowden | |
| | Luke Whiley | |
| P2860 | cites work | Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics | Q21560953 |
| | Recent advances in the application of metabolomics to Alzheimer's Disease | Q26828606 |
| | Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid | Q28115048 |
| | Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers | Q29620245 |
| | Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? | Q30441141 |
| | Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study | Q33895897 |
| | Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer's disease. | Q34064292 |
| | Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss | Q34106300 |
| | MIND diet associated with reduced incidence of Alzheimer's disease | Q34462761 |
| | Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. | Q34723925 |
| | Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers. | Q50644235 |
| | Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. | Q51949735 |
| | Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease. | Q54996405 |
| | In-Vial Dual Extraction for Direct LC-MS Analysis of Plasma for Comprehensive and Highly Reproducible Metabolic Fingerprinting | Q59622206 |
| | Soluble oligomers of amyloid-beta peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway | Q83180434 |
| | Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer's disease | Q35034769 |
| | Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. | Q35710041 |
| | Endocannabinoid signalling and the deteriorating brain | Q35754490 |
| | Biologically active sphingolipids in cancer pathogenesis and treatment | Q35852313 |
| | Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II. | Q36149981 |
| | Human serum metabolic profiles are age dependent | Q36498753 |
| | Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease | Q36604677 |
| | Increased ceramide in brains with Alzheimer's and other neurodegenerative diseases | Q36814487 |
| | Biomarkers for disease modification trials--the innovative medicines initiative and AddNeuroMed. | Q36892081 |
| | Alzheimer disease in the United States (2010-2050) estimated using the 2010 census | Q37035610 |
| | Blood metabolite markers of cognitive performance and brain function in aging | Q37057711 |
| | Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals | Q37100094 |
| | Plasma phospholipids identify antecedent memory impairment in older adults. | Q37714213 |
| | Ceramide-orchestrated signalling in cancer cells. | Q38067062 |
| | Metabolic Modifications in Human Biofluids Suggest the Involvement of Sphingolipid, Antioxidant, and Glutamate Metabolism in Alzheimer's Disease Pathogenesis | Q38401864 |
| | Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis | Q39332217 |
| | Astroglial expression of ceramide in Alzheimer's disease brains: a role during neuronal apoptosis. | Q40482351 |
| | 2015 Alzheimer's disease facts and figures | Q40928952 |
| | Quantitative and Wide-Ranging Profiling of Phospholipids in Human Plasma by Two-dimensional Liquid Chromatography/Mass Spectrometry | Q42827068 |
| | Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis | Q44370232 |
| | Neuropsychological and behavioural correlates of CSF biomarkers in dementia | Q46909660 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| | ceramides | Q424213 |
| | phosphatidylcholine | Q650187 |
| P304 | page(s) | 809-817 | |
| P577 | publication date | 2016-11-26 | |
| P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
| P1476 | title | Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease | |
| P478 | volume | 60 | |